
EHA 2021: fixed-duration therapies and sequencing in CLL
VJHemOnc Podcast
00:00
Sequencing of targeted therapies for CLL treatment and considerations for drug selection
This chapter explores the sequencing of targeted therapies for the treatment of CLL, taking into account factors such as initial therapy, drug tolerance, and disease progression. The speaker discusses specific drugs and their effectiveness in different patient scenarios, as well as the use of combination treatment strategies and the need for further data in understanding therapy sequencing in CLL.
Transcript
Play full episode